GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » LakeShore Biopharma Co Ltd (NAS:LSB) » Definitions » Retained Earnings

LSB (LakeShore Biopharma Co) Retained Earnings : $-323.20 Mil (As of Sep. 2024)


View and export this data going back to 2023. Start your Free Trial

What is LakeShore Biopharma Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. LakeShore Biopharma Co's retained earnings for the quarter that ended in Sep. 2024 was $-323.20 Mil.

LakeShore Biopharma Co's quarterly retained earnings declined from Sep. 2023 ($-280.71 Mil) to Mar. 2024 ($-320.42 Mil) and declined from Mar. 2024 ($-320.42 Mil) to Sep. 2024 ($-323.20 Mil).

LakeShore Biopharma Co's annual retained earnings declined from Mar. 2022 ($-250.70 Mil) to Mar. 2023 ($-271.96 Mil) and declined from Mar. 2023 ($-271.96 Mil) to Mar. 2024 ($-320.42 Mil).


LakeShore Biopharma Co Retained Earnings Historical Data

The historical data trend for LakeShore Biopharma Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

LakeShore Biopharma Co Retained Earnings Chart

LakeShore Biopharma Co Annual Data
Trend Mar21 Mar22 Mar23 Mar24
Retained Earnings
-207.94 -250.70 -271.96 -320.42

LakeShore Biopharma Co Quarterly Data
Mar21 Mar22 Jun22 Sep22 Mar23 Jun23 Sep23 Mar24 Sep24
Retained Earnings Get a 7-Day Free Trial Premium Member Only -271.96 -271.40 -280.71 -320.42 -323.20

LakeShore Biopharma Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


LakeShore Biopharma Co  (NAS:LSB) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


LakeShore Biopharma Co Business Description

Traded in Other Exchanges
Address
38 Yongda Road, Building No. 2, Daxing Biomedical Industry Park, Daxing District, Beijing, CHN, 102629
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.